U-Neuron Biomedical (ROCO:6973) Long-Term Capital Lease Obligation : NT$4.90 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical Long-Term Capital Lease Obligation?

U-Neuron Biomedical's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$4.90 Mil.

U-Neuron Biomedical's quarterly Long-Term Capital Lease Obligation stayed the same from Dec. 2022 (NT$0.00 Mil) to Jun. 2023 (NT$0.00 Mil) but then increased from Jun. 2023 (NT$0.00 Mil) to Dec. 2023 (NT$4.90 Mil).

U-Neuron Biomedical's annual Long-Term Capital Lease Obligation stayed the same from Dec. 2021 (NT$0.00 Mil) to Dec. 2022 (NT$0.00 Mil) but then increased from Dec. 2022 (NT$0.00 Mil) to Dec. 2023 (NT$4.90 Mil).

U-Neuron Biomedical Long-Term Capital Lease Obligation Historical Data

The historical data trend for U-Neuron Biomedical's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical Long-Term Capital Lease Obligation Chart

U-Neuron Biomedical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

4.90

U-Neuron Biomedical Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	-	-	-	-	4.90

U-Neuron Biomedical (ROCO:6973) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

U-Neuron Biomedical Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

U-Neuron Biomedical (ROCO:6973) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

https://en.u-neuron.com

U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines